Celsus Therapeutics Provides Year End 2013 Financial Results and Corporate Highlights

NEW YORK AND LONDON

Celsus Therapeutics Plc (NASDAQ:CLTX), an emerging growth, development-stage biotech company, today announced its financial results and provided a review of the twelve month period ended December 31, 2013.

Click here for the full press release